DHEA

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Selected references

  1. Finckh A, Berner IC, Aubry-Rozier B, et al. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.J Rheumatol. 2005 Jul;32(7):1336-40.
  2. Johannsson G, Burman P, Wiren L, et al. A. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 2002;87(5):2046-2052.
  3. Nachshoni T, Ebert T, Abramovitch Y, et al. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial.Schizophr Res. 2005 Nov 15;79(2-3):251-6.
  4. Parsons TD, Kratz KM, Thompson E, et al. Dhea supplementation and cognition in postmenopausal women.Int J Neurosci. 2006 Feb;116(2):141-55.
  5. Pillemer SR, Brennan MT, Sankar V, et al. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome. Arthritis Rheum. 8-15-2004;51(4):601-604.
  6. Rabkin JG, McElhiney MC, Rabkin R, et al. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry. 2006 Jan;163(1):59-66.
  7. Shoptaw S, Majewska MD, Wilkins J, et al. Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Exp.Clin.Psychopharmacol. 2004;12(2):126-135.
  8. Strous RD, Maayan R, Lapidus R, et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 2003;60(2):133-141.
  9. Sugino M, Ohsawa N, Ito T, et al. A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology 1998;51(2):586-589.
  10. Vakina TN, Shutov AM, Shalina SV, et al. [Dehydroepiandrosterone and sexual function in men with chronic prostatitis]. Urologiia. 2003;(1):49-52.
  11. van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 1999;8(3):181-187.
  12. Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin.Endocrinol.(Oxf) 2000;53(5):561-568.
  13. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 11-10-2004;292(18):2243-2248.
  14. Wolkowitz OM, Costa ME, Yaffe K, et al. Double-blind dehydroepiandrosterone treatment of Alzheimer's disease. 152nd Annual Meeting of the American Psychiatric Association 1999.
  15. Wolkowitz OM, Reus VI, Roberts E, et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 2-1-1997;41(3):311-318.

NS_patient-dhea

Portions of this document last updated:

Sept. 1, 2009

THIS EVIDENCE-BASED MONOGRAPH WAS PREPARED BY
THE NATURAL STANDARD RESEARCH COLLABORATION
(www.naturalstandard.com)


Text Size: smaller largerlarger